Sanarus raises $3M to battle breast cancer
Sanarus Medical, maker of a device used to diagnose and treat breast cancer, brought in $3 million in convertible note funding from existing investors, reports VentureWire. It’s currently working on a product that uses ultrasound technology to detect the early stages of the disease.
The Pleasanton, Calif. company already has several devices on the market, many of which are based on cryotechnology — basically, the freezing of small, targeted sections of breast tissue — which gives… Continue Reading
Life sciences briefing: Tuesday, Dec. 4, 2007
Featured companies: AgraQuest, BridgeHealth, CardioMems, Collegium Pharmaceutical, Emergin, Entegrion, gDiapers, Precision Therapeutics, PregLem
UPDATED: Expanded items on Entegrion, Collegium, and gDiapers. Added CardioMems item. New items posted on AgraQuest (link), BridgeHealth (link) and Precision Therapeutics (link).
Entegrion draws $4.7M for bleeding control — Entegrion, a Research Triangle Park, N.C., biotech focused on products that stop bleeding, raised $4.7 million in a second funding round, VentureWire reports (subscription req’d). Investors included BD Ventures, Catalysta Partners and unnamed individuals.
Entegrion’s main product… Continue Reading
Sanuras, breat tumor device company raises $15M
Sanarus Medical, a Pleasanton, Calif. company that makes a device to treat breast tumors, has raised $15 million in fifth round of funding, according to a regulatory filing cited by PE Week.
Investors included Easton Capital Partners, Alta Partners, Forward Ventures, Channel Medical Partners, Federated Kaufman Fund, Pequot Private Equity and U.S. Venture Partners. The company has now raised around $72 million in funding.